Subscribers,

The markets are in turmoil. Quite frankly, there is no other way to describe the situation that is upon us.

But as I've said many times over the years, there is always a silver lining in the markets. 

The reason why we trade micro and small caps is because they don't follow market trends. In fact, they don't pay any attention to the market whether its up or down.

So today I've got a brand new trade idea that we think could bring some significant upside.

Get Green Hygienics Holdings Inc (GRYN) on your screen immediately.

GRYN was trading at almost $2.50 just a few months ago. Today it is at $0.84.

We believe GRYN is ready for a major bounce higher, and today could just be the beginning. 



Hygienics is the science of preserving and promoting the health of individuals, communities and the planet. In an age where pharmaceuticals and the food supply are contributing factors in destroying our collective health, it is critical that we look to change this.

GRYN's objective is to be part of creating a solution and profit by it as a result of doing it well. Green Hygienics is establishing itself as a leader in the advancement of science-driven hemp cultivation systems with the objective in mind of providing the market with the best possible product and experience.

Their collective experience within the agricultural field in science and innovation is extensive. The company will grow by; generating revenues from the cultivation and sales of premium grade hemp and hemp derived products, developing and licensing valuable intellectual property assets, making strategic acquisitions, and creating trusted global consumer brands.

Green Hygienics Holdings Inc. (GRYN) is an innovative, full-scope, science-driven, premium hemp branding enterprise focused on the cultivation and processing of industrial hemp for cannabinoids (“CBD, CBG, CBN etc.”). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC) making it an ordinary agricultural commodity.

GRYN's mission is to grow the company in a sustainable and profitable manner to be one of the largest industrial hemp for CBD producers in North America. The company will adhere to the highest standards of operations in consistently delivering safe and premium quality products to consumers. The Company intends to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace.

The Company’s business model includes generating revenues from the sale of hemp and premium-grade CBD products; creating trusted global consumer brands; developing valuable IP; and growing the company rapidly through strategic acquisitions. For prospective acquisitions, the Company will act as a business accelerator and a vertical integrator to support rapid growth and development of companies with extraordinary potential.

For more information, visit www.GreenHygienics.com

Recent News...

Green Hygienics Holdings Inc. Expands Management Team, Advisory Board to Lead Key Business Strategies

SAN DIEGO, Feb. 18, 2020 /PRNewswire/ -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GRYN" or the "Company"), an innovative premium hemp cultivation and branding enterprise, announces the appointment of three experienced professionals to its management team. The addition of the following individuals will be key in supporting the Company's strategy to advancing its position becoming a leader in the North American Hemp Industry.   

Kyle MacKinnon, BCom - Chief Operating Officer 
Mr. MacKinnon has a multi-faceted and in-depth understanding of the CBD Industry, including vast knowledge of cannabis processing. Previously, as the Business Development Manager for Advanced Extraction, a leader in CO2 Supercritical Fluid Extraction systems, Kyle built relationships with some of the largest Cannabis companies in the world and helped to guide the company through rapid growth and regulatory challenges in the technology and processing sectors of the Cannabis industry. This firsthand knowledge and experience is invaluable in supporting the Company in developing its own processing capabilities.

As COO Kyle will assist the company in all areas of day to day business operations. With over 20 years Sales and Management experience, Kyle is well suited to drive business development, maintain administrative efforts, deliver superior and sustainable product lines, and provide a platform for strong growth.

Todd Mueller - Chief Financial Officer
Mr. Mueller is a seasoned executive who has held executive senior level positions for both private and public traded companies during his over 30-year career. For the past 15 years, Todd has worked as a fractional CFO for a variety of client companies providing his talents to build highly effective financial processes and procedures to handle rapid growth, provide disciplines and leadership, and raise the appropriate financial capital to provide stability during all stages of the company's life.

In addition, Mr. Mueller is adept at providing projected financial, valuation and cash management modeling that supports strategic executive management of the company for day-to-day and projected future. He is regarded as a highly analytical decision maker, experienced in building companies, along with a proven history of generating corporate productivity. Mr. Mueller has secured over $300 million in public offerings and over $100 million in private placement offerings with full knowledge of Registration Statements and Private Placement documents and the required reporting, respectively.

David Racz - Advisory Board
Mr. Racz has held global, senior-level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. Mr. Racz began his pharmaceutical career at Pfizer Pharmaceuticals where he became Vice President of Sales and Human Resources. Mr. Racz managed the largest expansion in Pfizer's sale force in history. Shortly thereafter, SmithKlineBeecham recruited Mr. Racz to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia and South Africa in Sales, Marketing and Research and Development. Mr. Racz was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham. In 2002, Mr. Racz was recruited by Novartis Pharmaceuticals as Senior Vice President North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in Pharmaceutical Operations, Global Oncology, Manufacturing and R&D. Mr. Racz was Senior Vice President for Mona Vie Inc. ("Mona Vie"), the fastest growing private company in the food and beverage industry incorporated in 2003 with annual sales in excess of $942 million and growth of over 100% per quarter for a three-year period.

In addition, Mr. Racz has served on various boards of both private and public companies, in the pharmaceutical, consumer brands and CBD space. His primary areas of expertise reside in aligning business strategy with operational strategy, management systems, as well as merger and acquisition related activities. David also served as a Medical Service Corp Officer in United States Army, achieving the rank of Major and was awarded numerous times for service and merit. He earned his BS from Wayne State University and his MS from Troy University.

"Quality people build a quality company and our business model includes ensuring our team is vested. Each of the professionals introduced in this and the preceding announcements add real value to GRYN's growth strategy. This is only the beginning of the industrial hemp industry and are pleased to welcome these gentlemen as we compete in this incredible market," stated GRYN CEO Ron Loudoun and further added, "After just several months of very hard work and capital investment in the Company's first property, the appraisal came in at a valuation of $18M. We are in discussions with lenders for a refinancing on the farm as well as a new financing to close on the acquisition of the office and warehouse building in Poway. There will be two valued properties on our balance sheet; the first to conduct cultivation and processing, and the second to execute manufacturing and distribution from. In addition to this, we believe once we demonstrate the ability to deliver significant cash flow in 2020, the Company will be in position to go to the next level."

To read in full visit https://finance.yahoo.com/news/green-hygienics-holdings-inc-expands-134700378.html

We think GRYN could deliver plenty of upside in the coming days and weeks. After this major pullback from around $2.50 to around $0.80, there is lots of bounce left in this cat.

Get GRYN on your screen now, do your research and be ready to trade when the markets open.


All the best.

SmallCapMomo.com

picks@smallcapmomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.